“…17,[37][38][39] In addition, there have been attempts to elucidate the treatment mechanism of moxibustion for fatigue in animal studies, which have suggested that it may be related to modulation of inflammatory cytokines and neurotransmitters, such as 5-hydroxyteyptamine and dopamine, in the hippocampus and reduced serum malonaldehyde levels. 9,40 When evaluating the therapeutic effect in CRF patients, placebo response is an important factor to consider. 41 The placebo response rate of CRF patients reportedly varies from 27% to 60%, and if the subjects are women with higher anxiety at baseline, placebo response will be higher.…”